Jump to main content
Jump to site search

Issue 11, 2005
Previous Article Next Article

Synthesis and biological evaluation of novel fumagillin and ovalicin analogues

Author affiliations

Abstract

A promising approach among the numerous efforts to cure cancer is the interruption of the tumour-induced formation of new blood vessels (angiogenesis). By suppressing angiogenesis with drugs, the tumour can neither grow to a life threatening size, nor metastasize. The natural product fumagillin 1 and the structurally related ovalicin 2 are two of the most potent anti-angiogenic compounds. Here, we report the design and synthesis of novel fumagillin and ovalicin analogues lacking reactive epoxy functionalities, which were thought to be responsible for the severe toxic side-effects observed. We also report a new synthetic approach and the determination of the anti-angiogenic properties of these compounds in endothelial cells.

Graphical abstract: Synthesis and biological evaluation of novel fumagillin and ovalicin analogues

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Mar 2005, accepted on 13 Apr 2005 and first published on 22 Apr 2005


Article type: Paper
DOI: 10.1039/B503163J
Citation: Org. Biomol. Chem., 2005,3, 2150-2154
  •   Request permissions

    Synthesis and biological evaluation of novel fumagillin and ovalicin analogues

    R. Mazitschek, A. Huwe and A. Giannis, Org. Biomol. Chem., 2005, 3, 2150
    DOI: 10.1039/B503163J

Search articles by author

Spotlight

Advertisements